LANSOPRAZOLE

lansoprazole 30 mg orally disintegrating tablet, 28

LANSOPRAZOLE (9477T)

lansoprazole 30 mg orally disintegrating tablet, 28
9477T
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  8775

Indication: Peptic ulcer
Treatment phase: Initial treatment

Restriction  8774

Indication: Gastro-oesophageal reflux disease
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 28 # of repeats: 1 DPMQ: $18.09 Max safety net: $19.57 General Patient Charge: $22.36
Available brands
APO-Lansoprazole ODT
Lansoprazole ODT GH
Zopral ODT
Zoton FasTabs
*Additional charge for this brand is $4.68
 DPMQ: $22.77 Max safety net: $19.57 General Patient Charge: $27.04